메뉴 건너뛰기




Volumn 15, Issue 6, 2011, Pages 907-915

Safety and efficacy of administering the maximal dose of candesartan in renal transplant recipients

Author keywords

Albuminuria; Anemia; Hyperkalemia

Indexed keywords

CANDESARTAN; CREATININE; HEMOGLOBIN; POTASSIUM;

EID: 84855274437     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0503-4     Document Type: Article
Times cited : (2)

References (40)
  • 2
    • 84930064073 scopus 로고    scopus 로고
    • The UNOS Renal Transplant Registry
    • Cecka JM. The UNOS Renal Transplant Registry. Clin Transpl. 2002:1-20.
    • (2002) Clin Transpl , pp. 1-20
    • Cecka, J.M.1
  • 3
    • 0027470121 scopus 로고
    • Half-life and risk factors for kidney transplant outcome - Importance of death with function
    • AJ Matas KJ Gillingham DE Sutherland 1993 Half-life and risk factors for kidney transplant outcome-importance of death with function Transplantation 55 757 761 8475549 10.1097/00007890-199304000-00014 1:STN:280:DyaK3s3jsFaktw%3D%3D (Pubitemid 23122042)
    • (1993) Transplantation , vol.55 , Issue.4 , pp. 757-761
    • Matas, A.J.1    Gillingham, K.J.2    Sutherland, D.E.R.3
  • 4
    • 33751330243 scopus 로고    scopus 로고
    • The aetiology and pathogenesis of chronic allograft nephropathy
    • DOI 10.1016/j.trim.2006.10.001, PII S0966327406001377
    • PJ Yates ML Nicholson 2006 The aetiology and pathogenesis of chronic allograft nephropathy Transpl Immunol 16 148 157 17138047 10.1016/j.trim.2006. 10.001 1:CAS:528:DC%2BD28Xht1Oht7nL (Pubitemid 44809923)
    • (2006) Transplant Immunology , vol.16 , Issue.3-4 , pp. 148-157
    • Yates, P.J.1    Nicholson, M.L.2
  • 5
    • 0029081936 scopus 로고
    • Effect of having a functioning cadaveric renal transplant on cardiovascular mortality risk in patients on renal replacement therapy
    • 7478127 1:STN:280:DyaK28%2FgtVOjsw%3D%3D
    • A Surdacki E Wieczorek-Surdacka W Sułowicz JS Dubiel 1995 Effect of having a functioning cadaveric renal transplant on cardiovascular mortality risk in patients on renal replacement therapy Nephrol Dial Transplant 10 1218 1223 7478127 1:STN:280:DyaK28%2FgtVOjsw%3D%3D
    • (1995) Nephrol Dial Transplant , vol.10 , pp. 1218-1223
    • Surdacki, A.1    Wieczorek-Surdacka, E.2    Sułowicz, W.3    Dubiel, J.S.4
  • 6
    • 0032892189 scopus 로고    scopus 로고
    • Electrocardiogram and outcome following renal transplantation [2]
    • DOI 10.1159/000045258
    • D Kavanagh ST Morris DB Northridge RS Rodger AG Jardine 1999 Electrocardiogram and outcome following renal transplantation Nephron 81 109 110 9884432 10.1159/000045258 1:STN:280:DyaK1M7gt1KktA%3D%3D (Pubitemid 29041729)
    • (1999) Nephron , vol.81 , Issue.1 , pp. 109-110
    • Kavanagh, D.1    Morris, S.T.W.2    Northridge, D.B.3    Rodger, R.S.C.4    Jardine, A.G.5
  • 7
    • 4644312643 scopus 로고    scopus 로고
    • Cardiovascular disease in stable renal transplant patients in Norway: Morbidity and mortality during a 5-yr follow-up
    • DOI 10.1111/j.1399-0012.2004.00235.x
    • S Aakhus K Dahl TE Widerøe 2004 Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up Clin Transplant 18 596 604 15344967 10.1111/j.1399-0012.2004.00235.x (Pubitemid 39264361)
    • (2004) Clinical Transplantation , vol.18 , Issue.5 , pp. 596-604
    • Aakhus, S.1    Dahl, K.2    Wideroe, T.E.3
  • 8
    • 0242441465 scopus 로고    scopus 로고
    • Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
    • DOI 10.1161/01.HYP.0000102971.85504.7c
    • MJ Sarnak AS Levey AC Schoolwerth J Coresh B Culleton LL Hamm, et al. 2003 Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension 42 1050 1065 14604997 10.1161/01.HYP.0000102971.85504.7c 1:CAS:528:DC%2BD3sXosFCls70%3D (Pubitemid 37413751)
    • (2003) Hypertension , vol.42 , Issue.5 , pp. 1050-1065
    • Sarnak, M.J.1    Levey, A.S.2    Schoolwerth, A.C.3    Coresh, J.4    Culleton, B.5    Hamm, L.L.6    McCullough, P.A.7    Kasiske, B.L.8    Kelepouris, E.9    Klag, M.J.10    Parfrey, P.11    Pfeffer, M.12    Raij, L.13    Spinosa, D.J.14    Wilson, P.W.15
  • 9
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • National Kidney Foundation. 10.1016/S0272-6386(02)70081-4
    • National Kidney Foundation 2002 K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 S1 S266 10.1016/S0272-6386(02)70081-4
    • (2002) Am J Kidney Dis , vol.39
  • 11
  • 12
    • 0037378449 scopus 로고    scopus 로고
    • Proteinuria and the risk of developing end-stage renal disease
    • DOI 10.1046/j.1523-1755.2003.00868.x
    • K Iseki Y Ikemiya C Iseki S Takishita 2003 Proteinuria and the risk of developing end-stage renal disease Kidney Int 63 1468 1474 12631363 10.1046/j.1523-1755.2003.00868.x (Pubitemid 36350012)
    • (2003) Kidney International , vol.63 , Issue.4 , pp. 1468-1474
    • Iseki, K.1    Ikemiya, Y.2    Iseki, C.3    Takishita, S.4
  • 14
    • 0028838569 scopus 로고
    • Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study
    • 7574193 1:STN:280:DyaK28%2FjtVOntw%3D%3D
    • JC Peterson S Adler JM Burkart T Greene LA Hebert LG Hunsicker, et al. 1995 Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study Ann Intern Med 123 754 762 7574193 1:STN:280:DyaK28%2FjtVOntw%3D%3D
    • (1995) Ann Intern Med , vol.123 , pp. 754-762
    • Peterson, J.C.1    Adler, S.2    Burkart, J.M.3    Greene, T.4    Hebert, L.A.5    Hunsicker, L.G.6
  • 17
    • 68249133888 scopus 로고    scopus 로고
    • Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: Subanalysis of the CASE-J Study
    • 19390535 10.1038/hr.2009.44 1:CAS:528:DC%2BD1MXntVSqtrY%3D
    • T Saruta K Hayashi T Ogihara K Nakao T Fukui K Fukiyama, et al. 2009 Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: subanalysis of the CASE-J Study Hypertens Res 32 505 512 19390535 10.1038/hr.2009.44 1:CAS:528:DC%2BD1MXntVSqtrY%3D
    • (2009) Hypertens Res , vol.32 , pp. 505-512
    • Saruta, T.1    Hayashi, K.2    Ogihara, T.3    Nakao, K.4    Fukui, T.5    Fukiyama, K.6
  • 19
    • 33745188045 scopus 로고    scopus 로고
    • Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: A systematic review of the efficacy and safety data
    • 16797382 10.1053/j.ajkd.2006.04.077 1:CAS:528:DC%2BD28XnslSqsb8%3D
    • M MacKinnon S Shurraw A Akbari GA Knoll J Jaffey HD Clark 2006 Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data Am J Kidney Dis 48 8 20 16797382 10.1053/j.ajkd.2006.04.077 1:CAS:528: DC%2BD28XnslSqsb8%3D
    • (2006) Am J Kidney Dis , vol.48 , pp. 8-20
    • MacKinnon, M.1    Shurraw, S.2    Akbari, A.3    Knoll, G.A.4    Jaffey, J.5    Clark, H.D.6
  • 20
    • 33845760213 scopus 로고    scopus 로고
    • KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease
    • DOI 10.1053/j.ajkd.2006.12.005, PII S0272638606018439
    • National Kidney Foundation 2007 KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease Am J Kidney Dis 49 S12 S154 10.1053/j.ajkd.2006.12.005 (Pubitemid 46185743)
    • (2007) American Journal of Kidney Diseases , vol.49 , Issue.SUPPL. 2
  • 22
    • 0033970346 scopus 로고    scopus 로고
    • ACE inhibitors and angiotensin II antagonists in renal transplantation: An analysis of safety and efficacy
    • CE Stigant J Cohen M Vivera JS Zaltzman 2000 ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy Am J Kidney Dis 35 58 63 10620545 10.1016/S0272-6386(00)70302-7 1:CAS:528:DC%2BD3cXkvVygsw%3D%3D (Pubitemid 30027241)
    • (2000) American Journal of Kidney Diseases , vol.35 , Issue.1 , pp. 58-63
    • Stigant, C.E.1    Cohen, J.2    Vivera, M.3    Zaltzman, J.S.4
  • 23
    • 0031741629 scopus 로고    scopus 로고
    • Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients
    • 10.1046/j.1523-1755.1998.06827.x 1:CAS:528:DyaK1cXotVKgs7s%3D
    • D del Castillo JM Campistol L Guirado L Capdevilla JG Martínez P Pereira, et al. 1998 Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients Kidney Int 68 S135 S139 10.1046/j.1523-1755.1998.06827.x 1:CAS:528:DyaK1cXotVKgs7s%3D
    • (1998) Kidney Int , vol.68
    • Del Castillo, D.1    Campistol, J.M.2    Guirado, L.3    Capdevilla, L.4    Martínez, J.G.5    Pereira, P.6
  • 24
    • 65549111017 scopus 로고    scopus 로고
    • Revised equations for estimating glomerular filtration rate (GFR) from serum creatinine in Japan
    • 19339088 10.1053/j.ajkd.2008.12.034 1:CAS:528:DC%2BD1MXnslKku7c%3D
    • S Matsuo E Imai M Horio Y Yasuda K Tomita K Nitta, et al. 2009 Revised equations for estimating glomerular filtration rate (GFR) from serum creatinine in Japan Am J Kidney Dis 53 982 992 19339088 10.1053/j.ajkd.2008.12.034 1:CAS:528:DC%2BD1MXnslKku7c%3D
    • (2009) Am J Kidney Dis , vol.53 , pp. 982-992
    • Matsuo, S.1    Imai, E.2    Horio, M.3    Yasuda, Y.4    Tomita, K.5    Nitta, K.6
  • 25
    • 34247600668 scopus 로고    scopus 로고
    • Endogenous erythropoietin levels and anemia in long-term renal transplant recipients
    • DOI 10.1159/000100906
    • J Zadrazil P Horák V Horcicka J Zahálková P Strébl M Hrubý 2007 Endogenous erythropoietin levels and anemia in long-term renal transplant recipients Kidney Blood Press Res 30 108 116 17374961 10.1159/000100906 1:CAS:528:DC%2BD2sXkslagur8%3D (Pubitemid 46674915)
    • (2007) Kidney and Blood Pressure Research , vol.30 , Issue.2 , pp. 108-116
    • Zadrazil, J.1    Horak, P.2    Horcicka, V.3    Zahalkova, J.4    Strebl, P.5    Hruby, M.6
  • 26
    • 34547830273 scopus 로고    scopus 로고
    • Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation
    • DOI 10.1093/ndt/gfm100
    • KT Sinnamon AE Courtney AP Maxwell PT McNamee G Savage DG Fogarty 2007 Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation Nephrol Dial Transplant 22 1969 1973 17353209 10.1093/ndt/gfm100 1:CAS:528:DC%2BD2sXos12htL4%3D (Pubitemid 47244768)
    • (2007) Nephrology Dialysis Transplantation , vol.22 , Issue.7 , pp. 1969-1973
    • Sinnamon, K.T.1    Courtney, A.E.2    Maxwell, A.P.3    McNamee, P.T.4    Savage, G.5    Fogarty, D.G.6
  • 27
    • 33646773570 scopus 로고    scopus 로고
    • Posttransplantation anemia in adult renal allograft recipients: Prevalence and predictors
    • 10.1097/01.tp.0000205174.97275.b5
    • N Shah S Al-Khoury B Afzali A Covic A Roche J Marsh, et al. 2006 Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors Transplantation 8 1112 1118 10.1097/01.tp.0000205174.97275.b5
    • (2006) Transplantation , vol.8 , pp. 1112-1118
    • Shah, N.1    Al-Khoury, S.2    Afzali, B.3    Covic, A.4    Roche, A.5    Marsh, J.6
  • 28
    • 68749121092 scopus 로고    scopus 로고
    • Anemia after renal transplantation
    • 17342689 1:STN:280:DC%2BC3c%2Fhs1KqtQ%3D%3D
    • D Montanaro 2007 Anemia after renal transplantation G Ital Nefrol 24 13 22 17342689 1:STN:280:DC%2BC3c%2Fhs1KqtQ%3D%3D
    • (2007) G Ital Nefrol , vol.24 , pp. 13-22
    • Montanaro, D.1
  • 30
    • 3142530382 scopus 로고    scopus 로고
    • Pilot study of the optimum hematocrit for patients in the predialysis stage after renal transplantation
    • DOI 10.1016/j.transproceed.2004.04.089, PII S0041134504005214
    • T Kawaguchi T Moriyama K Suzuki M Hatori T Tanaka S Takahara H Yamanaka 2004 Pilot study of the optimum hematocrit for patients in the predialysis stage after renal transplantation Transplant Proc 36 1293 1296 15251315 10.1016/j.transproceed.2004.04.089 1:STN:280:DC%2BD2czkvFGisA%3D%3D (Pubitemid 38902960)
    • (2004) Transplantation Proceedings , vol.36 , Issue.5 , pp. 1293-1296
    • Kawaguchi, T.1    Moriyama, T.2    Suzuki, K.3    Hatori, M.4    Tanaka, T.5    Takahara, S.6    Yamanaka, H.7
  • 31
    • 0033974161 scopus 로고    scopus 로고
    • Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure
    • T Hayashi A Suzuki T Shoji M Togawa N Okada Y Tsubakihara E Imai M Hori 2000 Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure Am J Kidney Dis 35 250 256 10676724 10.1016/S0272-6386(00)70334-9 1:CAS:528:DC%2BD3cXhtFSitbY%3D (Pubitemid 30070847)
    • (2000) American Journal of Kidney Diseases , vol.35 , Issue.2 , pp. 250-256
    • Hayashi, T.1    Suzuki, A.2    Shoji, T.3    Togawa, M.4    Okada, N.5    Tsubakihara, Y.6    Imai, E.7    Hori, M.8
  • 32
    • 68749120643 scopus 로고    scopus 로고
    • Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients
    • 19352589 10.1007/s10157-009-0170-x
    • N Kawada T Moriyama N Ichimaru R Imamura I Matsui Y Takabatake Y Nagasawa Y Isaka Y Kojima Y Kokado H Rakugi E Imai S Takahara 2009 Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients Clin Exp Nephrol 13 355 360 19352589 10.1007/s10157-009-0170-x
    • (2009) Clin Exp Nephrol , vol.13 , pp. 355-360
    • Kawada, N.1    Moriyama, T.2    Ichimaru, N.3    Imamura, R.4    Matsui, I.5    Takabatake, Y.6    Nagasawa, Y.7    Isaka, Y.8    Kojima, Y.9    Kokado, Y.10    Rakugi, H.11    Imai, E.12    Takahara, S.13
  • 33
    • 33646198401 scopus 로고    scopus 로고
    • A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period
    • 16431893 10.1093/ndt/gfk058 1:CAS:528:DC%2BD28XjslKqsrk%3D
    • RN Formica Jr AL Friedman MI Lorber JD Smith T Eisen MJ Bia 2006 A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period Nephrol Dial Transplant 21 1389 1394 16431893 10.1093/ndt/gfk058 1:CAS:528:DC%2BD28XjslKqsrk%3D
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 1389-1394
    • Formica Jr., R.N.1    Friedman, A.L.2    Lorber, M.I.3    Smith, J.D.4    Eisen, T.5    Bia, M.J.6
  • 34
    • 77952297743 scopus 로고    scopus 로고
    • Serum potassium and outcomes in CKD: Insights from the RRI-CKD cohort study
    • 20203167 10.2215/CJN.05850809 1:CAS:528:DC%2BC3cXnsVyrtb4%3D
    • S Korgaonkar A Tilea BW Gillespie M Kiser G Eisele F Finkelstein, et al. 2010 Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study Clin J Am Soc Nephrol 5 762 769 20203167 10.2215/CJN.05850809 1:CAS:528:DC%2BC3cXnsVyrtb4%3D
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 762-769
    • Korgaonkar, S.1    Tilea, A.2    Gillespie, B.W.3    Kiser, M.4    Eisele, G.5    Finkelstein, F.6
  • 35
    • 0031740870 scopus 로고    scopus 로고
    • Treatment of hypertension after renal transplantation: Long-term efficacy of verapamil, enalapril, and doxazosin
    • 10.1046/j.1523-1755.1998.06826.x
    • A Martínez-Castelao M Hueso V Sanz J Rejas J Alsina JM Grinyó 1998 Treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin Kidney Int 68 S130 S134 10.1046/j.1523-1755.1998.06826.x
    • (1998) Kidney Int , vol.68
    • Martínez-Castelao, A.1    Hueso, M.2    Sanz, V.3    Rejas, J.4    Alsina, J.5    Grinyó, J.M.6
  • 36
    • 84855278441 scopus 로고    scopus 로고
    • Stratifying risk in chronic kidney disease: An observational study of UK guidelines for measuring total proteinuria and albuminuria
    • Methven S, Traynor JP, Hair MD, Oreilly DSJ, Deighan CJ, MacGregor MS. Stratifying risk in chronic kidney disease: an observational study of UK guidelines for measuring total proteinuria and albuminuria. Q J Med. 2011;104:663-70.
    • (2011) Q J Med , vol.104 , pp. 663-670
    • Methven, S.1    Traynor, J.P.2    Hair, M.D.3    Dsj, O.4    Deighan, C.J.5    MacGregor, M.S.6
  • 38
    • 79954503423 scopus 로고    scopus 로고
    • Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients
    • 21458900 10.1053/j.ajkd.2010.12.022 1:CAS:528:DC%2BC3MXkvVSksbo%3D
    • FL Nauta SJ Bakker W van Oeveren G Navis JJ van der Heide H van Goor PE de Jong RT Gansevoort 2011 Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients Am J Kidney Dis 57 733 743 21458900 10.1053/j.ajkd.2010.12.022 1:CAS:528:DC%2BC3MXkvVSksbo%3D
    • (2011) Am J Kidney Dis , vol.57 , pp. 733-743
    • Nauta, F.L.1    Bakker, S.J.2    Van Oeveren, W.3    Navis, G.4    Van Der Heide, J.J.5    Van Goor, H.6    De Jong, P.E.7    Gansevoort, R.T.8
  • 39
    • 77950187294 scopus 로고    scopus 로고
    • Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): A prespecified secondary analysis of a randomised controlled trial
    • 20170948 10.1016/S0140-6736(09)62100-0 1:CAS:528:DC%2BC3cXktlGitr8%3D
    • GL Bakris PA Sarafidis MR Weir B Dahlöf B Pitt K Jamerson, et al. 2010 Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial Lancet 375 1173 1181 20170948 10.1016/S0140-6736(09)62100-0 1:CAS:528:DC%2BC3cXktlGitr8%3D
    • (2010) Lancet , vol.375 , pp. 1173-1181
    • Bakris, G.L.1    Sarafidis, P.A.2    Weir, M.R.3    Dahlöf, B.4    Pitt, B.5    Jamerson, K.6
  • 40
    • 34548301629 scopus 로고    scopus 로고
    • Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence
    • DOI 10.1111/j.1600-6143.2007.01928.x
    • S Hiremath D Fergusson S Doucette AV Mulay GA Knoll 2007 Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence Am J Transplant 7 2350 2360 17845569 10.1111/j.1600-6143.2007. 01928.x 1:STN:280:DC%2BD2srjtF2ltg%3D%3D (Pubitemid 47347851)
    • (2007) American Journal of Transplantation , vol.7 , Issue.10 , pp. 2350-2360
    • Hiremath, S.1    Fergusson, D.2    Doucette, S.3    Mulay, A.V.4    Knoll, G.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.